arrow
返回
C

Claire Lucas

university of liverpool

20H指数
75论文数
2.3K被引数
收录论文 14
发表时间
SET-PP2A complex as a new therapeutic target in KMT2A (MLL) rearranged AML
err2023-10-27
err1
errOAAI
errDi Mambro, Antonella; Arroyo-Berdugo, Yoana; Fioretti, Tiziana; Randles, Michael; Cozzuto, Luca; Rajeeve, Vinothini; Cevenini, Armando; Austin, Michael J.; Esposito, Gabriella; Ponomarenko, Julia; Lucas, Claire M.; Cutillas, Pedro; Gribben, John; Williams, Owen; Calle, Yolanda; Patel, Bela; Esposito, Maria Teresa
err分享
err收藏
Cancerous inhibitor of protein phosphatase 2A (CIP2A) modifies energy metabolism via 5′ AMP-activated protein kinase signalling in malignant cells
err2019-08-15
err4
PREAI
errAustin, James A.; Jenkins, Rosalind E.; Austin, Gemma M.; Glenn, Mark A.; Dunn, Karen; Scott, Laura; Lucas, Claire M.; Clark, Richard E.
err分享
err收藏
Comment on PP2A inhibition sensitizes cancer stem cells to ABL tyrosine kinase inhibitors in BCR-ABL human leukemia
err2019-07-17
err6
errOAAI
errPerrotti, Danilo; Agarwal, Anupriya; Lucas, Claire M.; Narla, Goutham; Neviani, Paolo; Odero, Maria D.; Ruvolo, Peter P.; Verrills, Nicole M.
err分享
err收藏
CIP2A- and SETBP1-mediated PP2A inhibition reveals AKT S473 phosphorylation to be a new biomarker in AML
err2018-04-27
err15
errOAAI
errLucas, Claire M.; Scott, Laura J.; Carmell, Natasha; Holcroft, Alison K.; Hills, Robert K.; Burnett, Alan K.; Clark, Richard E.
err分享
err收藏
High CIP2A levels correlate with an antiapoptotic phenotype that can be overcome by targeting BCL-XL in chronic myeloid leukemia
errLEUKEMIA
IF13.4
err2016-02-29
err24
errOAAI
errLucas, C. M.; Milani, M.; Butterworth, M.; Carmell, N.; Scott, L. J.; Clark, R. E.; Cohen, G. M.; Varadarajan, S.
err分享
err收藏
Turning Squalene into Cationic Lipid Allows a Delivery of siRNA in Cultured Cells
err2015-06-01
err6
errOAAI
errBertrand, Jean-Remi; Lucas, Claire; Ngoc Minh Pham; Durieu, Catherine; Couvreur, Patrick; Malvy, Claude Paul; Desmaele, Didier
err分享
err收藏
Second generation tyrosine kinase inhibitors prevent disease progression in high-risk (high CIP2A) chronic myeloid leukaemia patients
errLEUKEMIA
IF13.4
err2015-03-13
err31
PREAI
errLucas, C. M.; Harris, R. J.; Holcroft, A. K.; Scott, L. J.; Carmell, N.; McDonald, E.; Polydoros, F.; Clark, R. E.
err分享
err收藏
Low leukotriene B4 receptor 1 leads to ALOX5 downregulation at diagnosis of chronic myeloid leukemia
err2014-09-05
err19
errOAAI
errLucas, Claire M.; Harris, Robert J.; Giannoudis, Athina; McDonald, Elizabeth; Clark, Richard E.
err分享
err收藏
The clinical significance of ABCC3 as an imatinib transporter in chronic myeloid leukaemia
errLEUKEMIA
IF13.4
err2014-01-20
err21
PREAI
errGiannoudis, A.; Davies, A.; Harris, R. J.; Lucas, C. M.; Pirmohamed, M.; Clark, R. E.
err分享
err收藏
err分享
err收藏
A population study of imatinib in chronic myeloid leukaemia demonstrates lower efficacy than in clinical trials
errLEUKEMIA
IF13.4
err2008-08-28
err92
PREAI
errLucas, C. M.; Wang, L.; Austin, G. M.; Knight, K.; Watmough, S. J.; Shwe, K. H.; Dasgupta, R.; Butt, Nauman M.; Galvani, D.; Hoyle, C. F.; Seale, J. R. C.; Clark, R. E.
err分享
err收藏
Chemokine receptors expression and migration potential of tumor-infiltrating and peripheral-expanded Vγ9Vδ2 T cells from renal cell carcinoma patients
err2008-04-01
err45
PREAI
errViey, Emilie; Lucas, Claire; Romagne, Francois; Escudier, Bernard; Chouaib, Salem; Caignard, Anne
err分享
err收藏